Consumption of Sugar-Sweetened Beverages in Paediatric Age: A Position Paper of the European Academy of Paediatrics and the European Childhood Obesity Group.


Journal

Annals of nutrition & metabolism
ISSN: 1421-9697
Titre abrégé: Ann Nutr Metab
Pays: Switzerland
ID NLM: 8105511

Informations de publication

Date de publication:
2019
Historique:
received: 08 01 2019
accepted: 21 03 2019
pubmed: 24 4 2019
medline: 15 5 2020
entrez: 24 4 2019
Statut: ppublish

Résumé

Health risks associated with the high consumption of sugar-sweetened beverages (SSBs) include overweight or obesity and their complications such as diabetes, as well as oral and dental decay, among others. The aim of the present statement is to inform health care professionals, parents, care-givers, teachers and school head teachers, stakeholders and governing bodies about the risks associated with drinking SSBs in infants, children and adolescents. We searched PubMed and the Cochrane databases for English language studies published from 2010 through October 1, 2018, for randomized clinical trials, meta-analyses, systematic reviews and observational studies (search terms are reported in eAppendix in the Supplement). We also manually searched the references of selected articles, reviews, meta-analyses and practice guidelines. Consumption of SSB by children and adolescents should be limited, and the consumption of water and other non-sweetened beverages should be promoted. Educational institutions such as nurseries, pre-schools and schools should offer unlimited access to drinking water, whereas the sale of SSBs should be banned.

Sections du résumé

BACKGROUND
Health risks associated with the high consumption of sugar-sweetened beverages (SSBs) include overweight or obesity and their complications such as diabetes, as well as oral and dental decay, among others.
AIM
The aim of the present statement is to inform health care professionals, parents, care-givers, teachers and school head teachers, stakeholders and governing bodies about the risks associated with drinking SSBs in infants, children and adolescents.
METHODS
We searched PubMed and the Cochrane databases for English language studies published from 2010 through October 1, 2018, for randomized clinical trials, meta-analyses, systematic reviews and observational studies (search terms are reported in eAppendix in the Supplement). We also manually searched the references of selected articles, reviews, meta-analyses and practice guidelines.
RECOMMENDATIONS
Consumption of SSB by children and adolescents should be limited, and the consumption of water and other non-sweetened beverages should be promoted. Educational institutions such as nurseries, pre-schools and schools should offer unlimited access to drinking water, whereas the sale of SSBs should be banned.

Identifiants

pubmed: 31013493
pii: 000499828
doi: 10.1159/000499828
doi:

Substances chimiques

Dietary Sugars 0

Types de publication

Consensus Development Conference Journal Article Practice Guideline Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

296-302

Informations de copyright

© 2019 S. Karger AG, Basel.

Auteurs

Katarzyna Dereń (K)

Medical Faculty, University of Rzeszów, Rzeszów, Poland, kderen@ur.edu.pl.
European Childhood Obesity Group, Brussels, Belgium, kderen@ur.edu.pl.

Daniel Weghuber (D)

Department of Pediatrics, Paracelsus Medical University, Salzburg, Austria.
European Childhood Obesity Group, Brussels, Belgium.

Margherita Caroli (M)

Paediatrician, Nutritionist, Brindisi, Italy.
European Childhood Obesity Group, Brussels, Belgium.

Berthold Koletzko (B)

Dr. von Hauner Children's Hospital, University of Munich Medical Centre, Ludwig -Maximilians-Universität Munich, Munich, Germany.

David Thivel (D)

Clermont Auvergne University, Clermont Ferrand, France.
European Childhood Obesity Group, Brussels, Belgium.

Marie-Laure Frelut (ML)

Pediatric Practice, Albi, France.
European Childhood Obesity Group, Brussels, Belgium.

Piotr Socha (P)

Department of Gastroenterology, Hepatology, Feeding Disorders and Pediatrics, The Children's Memorial Health Institute, Warsaw, Poland.

Zachi Grossman (Z)

Maccabi Health Services, Tel Aviv, Israel.
European Academy of Paediatrics, Brussels, Belgium.

Adamos Hadjipanayis (A)

Department of Paediatrics, Larnaca General Hospital, Inomenon Polition, Larnaca, Cyprus.
European Academy of Paediatrics, Brussels, Belgium.
European University Medical School, Nicosia, Cyprus.

Justyna Wyszyńska (J)

Medical Faculty, University of Rzeszów, Rzeszów, Poland.
European Childhood Obesity Group, Brussels, Belgium.

Artur Mazur (A)

Medical Faculty, University of Rzeszów, Rzeszów, Poland.
European Childhood Obesity Group, Brussels, Belgium.
European Academy of Paediatrics, Brussels, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH